Suppr超能文献

18F-FDG PET/CT在检测癌胚抗原(CEA)水平升高患者结直肠癌复发中的作用

The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.

作者信息

Ozkan Elgin, Soydal Cigdem, Araz Mine, Kir Kemal Metin, Ibis Erkan

机构信息

Department of Nuclear Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey.

出版信息

Nucl Med Commun. 2012 Apr;33(4):395-402. doi: 10.1097/MNM.0b013e32834f7dbe.

Abstract

INTRODUCTION

In this study we aimed to define the success of fluorine-18 (18F) fluorodeoxyglucose (FDG) PET/computed tomography (PET/CT) in detecting recurrent disease in our patient group with colorectal cancer (CRC) and elevated carcinoembryonic antigen (CEA) levels.

MATERIAL AND METHOD

Patients who had a previous diagnosis of CRC were searched retrospectively in our PET center database. Seventy-six 18F-FDG PET/CT studies between October 2006 and December 2010 of 69 patients (25 women, 44 men; mean age: 61.61 ± 4.1 years) with elevated CEA levels were evaluated. 18F-FDG PET/CT findings and concurrent abdominopelvic contrast-enhanced computed tomography (ceCT) findings were compared with histopathological findings and/or clinical follow-up data as the 'gold standard'.

RESULTS

In the patient-based analysis, the sensitivity and specificity of 18F-FDG PET/CT in the detection of disease recurrence were calculated as 97 and 61%, respectively. A statistically significant difference was found in frequencies of positive and negative 18F-FDG PET/CT findings between patients with or without recurrent disease by gold standard (P<0.05). There was no correlation between patients' serum CEA levels and lesions' maximum standardized uptake values (P=0.85). The sensitivity and specificity of ceCT were computed as 51 and 60%, respectively. In the evaluation of separate patient groups, although the sensitivity and specificity of 18F-FDG PET/CT were calculated as 100 and 60% in the group whose CEA level elevation was less than two-fold (5-9.9 ng/ml), these were 100 and 75% in the group with CEA elevation less than three-fold (10-14.9 ng/ml) and 95 and 62% in the group with elevation more than three-fold (≥ 15 ng/ml). The sensitivity and specificity of 18F-FDG PET/CT were computed as 98 and 85% in the lesion-based evaluation. The sensitivity and specificity of ceCT were 73 and 86%, respectively.

CONCLUSION

18F-FDG PET/CT is a safe imaging method that can be used in the determination of CRC recurrence in patients with elevated CEA levels, regardless of the CEA level.

摘要

引言

在本研究中,我们旨在确定氟-18(18F)氟脱氧葡萄糖(FDG)PET/计算机断层扫描(PET/CT)在检测我们的结直肠癌(CRC)患者组中复发疾病及癌胚抗原(CEA)水平升高方面的成功率。

材料与方法

在我们的PET中心数据库中对先前诊断为CRC的患者进行回顾性检索。评估了2006年10月至2010年12月期间69例(25例女性,44例男性;平均年龄:61.61±4.1岁)CEA水平升高患者的76次18F-FDG PET/CT检查。将18F-FDG PET/CT检查结果和同期腹盆腔增强计算机断层扫描(ceCT)结果与作为“金标准”的组织病理学结果和/或临床随访数据进行比较。

结果

在基于患者的分析中,18F-FDG PET/CT检测疾病复发的敏感性和特异性分别计算为97%和61%。通过金标准判断,有或无复发疾病的患者之间18F-FDG PET/CT阳性和阴性结果的频率存在统计学显著差异(P<0.05)。患者血清CEA水平与病变的最大标准化摄取值之间无相关性(P=0.85)。ceCT的敏感性和特异性分别计算为51%和60%。在对不同患者组的评估中,尽管在CEA水平升高小于两倍(5 - 9.9 ng/ml)的组中,18F-FDG PET/CT的敏感性和特异性计算为100%和60%,但在CEA升高小于三倍(10 - 14.9 ng/ml)的组中分别为100%和75%,在升高超过三倍(≥15 ng/ml)的组中分别为95%和62%。在基于病变的评估中,18F-FDG PET/CT的敏感性和特异性分别计算为98%和85%。ceCT的敏感性和特异性分别为73%和86%。

结论

18F-FDG PET/CT是一种安全的成像方法,可用于确定CEA水平升高的CRC患者的复发情况,无论CEA水平如何。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验